Issuer (NYSE: PATH) insider plans Rule 144 sale of common stock
Rhea-AI Filing Summary
An insider of PATH has filed a notice to sell 67,468 shares of common stock through Morgan Stanley Smith Barney LLC on or around 01/05/2026 on the NYSE, with an indicated aggregate market value of
The notice also lists prior Rule 10b5-1 sales for Ashim Gupta, showing a sale of 240,874 common shares on 10/09/2025 for gross proceeds of
Positive
- None.
Negative
- None.
FAQ
What insider share sale is disclosed for PATH in this notice?
The notice discloses that an insider plans to sell 67,468 shares of PATH common stock through Morgan Stanley Smith Barney LLC on or around 01/05/2026 on the NYSE, with an aggregate market value of
How were the PATH shares to be sold originally acquired?
The 67,468 common shares to be sold are tied to restricted stock units that were acquired from the issuer on 01/01/2026, with the form listing the nature of payment as N/A.
What prior 10b5-1 sales for PATH are reported in the past three months?
The filing reports Rule 10b5-1 sales for Ashim Gupta, showing that on 10/09/2025 he sold 240,874 PATH common shares, generating gross proceeds of
How many PATH common shares are reported as outstanding?
The document states that there are 460,443,681 PATH common shares outstanding in the class referenced for the planned sale.
Which broker is handling the planned PATH share sale and on which exchange?
The planned sale of 67,468 PATH common shares is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services on the NYSE.
What representation does the seller make about information on the issuer?
By signing the notice, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.